American Journal of Ophthalmology
Volume 142, Issue 1 , Pages 60-67.e1 , July 2006

Association of Blood Pressure Status With the Optic Disk Structure in Non-glaucoma Subjects: The Thessaloniki Eye Study

  • Fotis Topouzis, MD

      Affiliations

    • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • Corresponding Author InformationInquiries to Fotis Topouzis, MD, Aristotle University of Thessaloniki, II Department of Ophthalmology, General Hospital “Papageorgiou” Periferiaki Odos Thessalonikis N Efkarpia 56403, Thessaloniki, Greece
    • ,
  • Anne L. Coleman, MD, PhD

      Affiliations

    • Center for Eye Epidemiology, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
    • ,
  • Alon Harris, PhD

      Affiliations

    • Department of Ophthalmology, Indiana University, Indianapolis, Indiana
    • ,
  • Christian Jonescu-Cuypers, MD

      Affiliations

    • Department of Ophthalmology, University of Cologne, Cologne, Germany
    • ,
  • Fei Yu, PhD

      Affiliations

    • Center for Eye Epidemiology, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
    • ,
  • Leonidas Mavroudis, MD

      Affiliations

    • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • ,
  • Eleftherios Anastasopoulos, MD

      Affiliations

    • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • ,
  • Theofanis Pappas, MD

      Affiliations

    • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • ,
  • Archimidis Koskosas, MD

      Affiliations

    • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • ,
  • M. Roy Wilson, MD, MS

      Affiliations

    • Texas Tech University Health Sciences Center, Lubbock, Texas

,Accepted 10 February 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 See accompanying Editorial on page 144.Supported in part by the International Glaucoma Association, London, United Kingdom; UCLA Center for Eye Epidemiology, Los Angeles, California; Health Future Foundation, Creighton University, Omaha, Nebraska; Glaucoma Research and Education Foundation, Indianapolis, Indiana; Texas Tech University Health Sciences Center, Lubbock, Texas; Pfizer Inc, New York, New York; Merck and Co Inc, Whitehouse Station, New Jersey; Pharmacia Hellas, Athens, Greece; and Novartis Hellas, Athens, Greece. All the grants were unrestricted.

PII: S0002-9394(06)00350-3

doi: 10.1016/j.ajo.2006.02.055

American Journal of Ophthalmology
Volume 142, Issue 1 , Pages 60-67.e1 , July 2006

Article Tools

* Image Usage & Resolution